Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Charles River Laboratories International Inc (NYSE: CRL) was $145.29 for the day, up 0.17% from the previous closing price of $145.05. In other words, the price has increased by $0.17 from its previous closing price. On the day, 0.63 million shares were traded. CRL stock price reached its highest trading level at $147.0999 during the session, while it also had its lowest trading level at $143.06.
Ratios:
Our analysis of CRL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.67. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.93.
On May 14, 2025, TD Cowen Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $179.
Evercore ISI Upgraded its In-line to Outperform on May 08, 2025, while the target price for the stock was maintained at $170.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 15 ’25 when MASSARO GEORGE sold 140 shares for $137.57 per share. The transaction valued at 19,260 led to the insider holds 5,575 shares of the business.
MASSARO GEORGE sold 140 shares of CRL for $19,703 on May 14 ’25. The Director now owns 5,715 shares after completing the transaction at $140.73 per share. On May 13 ’25, another insider, LaPlume Joseph W, who serves as the EVP, Corp Strategy & Develop of the company, sold 500 shares for $145.41 each. As a result, the insider received 72,705 and left with 19,513 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRL now has a Market Capitalization of 7136019968 and an Enterprise Value of 9943445504. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 2.472 whereas that against EBITDA is 11.188.
Stock Price History:
The Beta on a monthly basis for CRL is 1.48, which has changed by -0.30692172 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, CRL has reached a high of $254.15, while it has fallen to a 52-week low of $91.86. The 50-Day Moving Average of the stock is 11.53%, while the 200-Day Moving Average is calculated to be -13.92%.
Shares Statistics:
CRL traded an average of 1.58M shares per day over the past three months and 813750 shares per day over the past ten days. A total of 49.12M shares are outstanding, with a floating share count of 48.50M. Insiders hold about 1.25% of the company’s shares, while institutions hold 109.95% stake in the company. Shares short for CRL as of 1748563200 were 2422321 with a Short Ratio of 1.54, compared to 1745971200 on 2643188. Therefore, it implies a Short% of Shares Outstanding of 2422321 and a Short% of Float of 5.6700002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
